Top Markets
#1 ONFA ONFA +225.70%
#2 Resolv wstUSR Resolv wstUSR +198.07%
#3 Noon Noon +41.33%
#4 Doge Strategy Doge Strategy +38.28%
#5 NKN NKN +36.47%
#6 DeAgentAI DeAgentAI +34.15%
#7 Liquid Mercury Liquid Mercury +32.29%
#8 StakeStone StakeStone +31.48%
#9 BLOCKv BLOCKv +24.65%
#10 OpenVPP OpenVPP +21.82%
Coin of the day
ONFA ONFA
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Rang in Aktien #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Aktienkurs
$154.51
Marktkapitalisierung
$55.98B
Veränderung (1 Tag)
-1.82%
Veränderung (1 Jahr)
-32.08%
Land
US
Handel Becton, Dickinson and Company (BDX)

Kategorie

Healthcare
P/S-Verhältnis für Becton, Dickinson and Company (BDX)
P/S-Verhältnis zum March 2026 TTM: 2.63
Laut den neuesten Finanzberichten und dem Aktienkurs von Becton, Dickinson and Company beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 2.63. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 3.46.
P/S-Verlauf für Becton, Dickinson and Company von 2000 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
2026 (TTM) 2.63 7.06%
2025 2.46 -29.05%
2024 3.46 -9.38%
2023 3.82 13.52%
2022 3.37 -7.13%
2021 3.62 -7.95%
2020 3.94 2.25%
2019 3.85 -7.58%
2018 4.17 20.46%
2017 3.46 15.84%
2016 2.99 17.19%
2015 2.55 0.33%
2014 2.54 7.48%
2013 2.36 15.16%
2012 2.05 -1.58%
2011 2.08 -12.26%
2010 2.38 1.52%
2009 2.34 -13.39%
2008 2.70 -13.13%
2007 3.11 4.69%
2006 2.97 25.13%
2005 2.37 -7.55%
2004 2.57 27.93%
2003 2.01 11.28%
2002 1.80 -26.44%
2001 2.45 36.00%
2000 1.80 0.00%
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
16.66 532.59%
US
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft
SOAGY.US
4.09 55.39%
DE
HOYA Corporation HOYA Corporation
HOYA Corporation
HOCPY.US
10.24 288.95%
JP
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.US
3.62 37.59%
CH
ResMed Inc. ResMed Inc.
ResMed Inc.
RMD.US
6.24 137.01%
US